跳至主要内容
临床试验/NCT07576621
NCT07576621已完成不适用

Evaluation of the Association Between Hypomagnesemia and Coagulopathy in Sepsis

Ain Shams University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1

研究概览

简要总结

This study aimed to investigate the association between hypomagnesemia and coagulopathy in patients with sepsis, with a focus on evaluating whether low serum magnesium levels are independently linked to the development of disseminated intravascular coagulation during intensive care unit admission.

详细描述

Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection. It remains a major global cause of morbidity and mortality in intensive care units (ICUs).

Hypomagnesemia, commonly observed in ICU patients, has been associated with poor outcomes, including increased need for mechanical ventilation and extended ICU stays. Its immunomodulatory and vasoprotective functions make it a key factor in sepsis pathophysiology.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 20 years at the time of Intensive Care Unit (ICU) admission.
  • Diagnosis of sepsis based on Sepsis-3 criteria [confirmed or suspected infection + Sequential Organ Failure Assessment (SOFA) score ≥ 2].
  • Admission to the ICU during the study period.
  • Serum magnesium level measured at ICU admission.
  • Coagulation parameters [e.g., platelet count, Prothrombin Time/International Normalized Ratio (PT-INR), fibrinogen, D-dimer] within 24 hours of ICU admission.
  • Complete clinical and laboratory data for calculating the International Society on Thrombosis and Haemostasis (ISTH) overt Disseminated Intravascular Coagulation (DIC) score.

排除标准

  • Patients with missing data on serum magnesium or coagulation markers at ICU admission.
  • ICU admissions due to non-infectious causes (e.g., trauma, elective surgery without infection).
  • Presence of pre-existing coagulopathy or hematologic malignancy affecting baseline coagulation (e.g., leukemia, hemophilia).
  • Known history of magnesium supplementation prior to ICU admission.
  • End-stage renal disease on dialysis, which may significantly alter magnesium handling.
  • Pregnant women, due to altered magnesium physiology.
  • Patients transferred from or to another hospital within 24 hours of ICU admission (incomplete follow-up).

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed hamoda

Resident of Intensive Care, Anaesthesia and Pain Management, Ain Shams University, Cairo, Egypt.

Ain Shams University

研究点 (1)

Loading locations...

相似试验